PharmD Info

A forum for Indian Pharmacy Professionals

Important: Registered today to have the complete access on this forum --- Register Here
It's an open forum for Indian Clinical and Hospital Pharmacists to discuss on designing, implementing, and monitoring a therapeutic plan that will produce specific therapeutic outcomes for the patient Eg:Antibiotic Policies, Pharmacist Interventions, Medication Therapy Management. DRP,s and Its Management.
Forum rules: Dear User, Kindly read our forum rules before you proceed with our PharmD Info, Your first 5 posts/topics requires moderator approval and this website is purely meant for educational and knowledge sharing purpose only so you should not make any topics/replies/messages which criticize, threaten or abuse any member, pharmacy governing bodies and organizations. Your post will be deleted automatically by our BB Pruning System if your topic is not viewed by members for more than 5 days. So, make sure that your topics and its related contents are unique and valuable. We expect you to be an active member of our forum to continue with your free membership.Kindly note that if a member received more than five warnings from moderator/members they will be blocked automatically by our Bulletin Board system.
  • User avatar
#2020
Epidemiological data is also important in decision making, when there is need to rank what issues to tackle first and to understand the magnitude of the use. For each individual patient there are individual circumstances. An interesting use of pharmacoepidemiology data is the use of data for individual prescribers and giving feedback to their prescribing pattern compared with other prescribers as done in the Rx-Pad studies
(http://www.ncbi.nlm.nih.gov/pubmed/23894178

Another example of use not on individual patients but in decision making was the recent issue of co-prescribing of different angiotensin-rening blockers (ARBs) and the increased risk of side-effects without added benefit. EMA then did a drug utilisation study to understand better how large the problem really was (not very large) and in what group of patients it was largest (most co-prescribing in the groups with the biggest risk as well) the report is publised on ENCEPP
here: http://www.encepp.eu/encepp/openAttachment/studyResult/4612
Similar Topics
Topics Statistics Last post
Walk in for Junior Data Analyst - Cognizant
by Admin  - 04 Mar 2018, 11:22  - In: Pharm D Jobs
0 Replies 
401 Views
by Admin
04 Mar 2018, 11:22
Syneos Health Hiring for Clinical Data Managers
by Admin  - 19 Jun 2018, 14:39  - In: Pharm D Jobs
0 Replies 
441 Views
by Admin
19 Jun 2018, 14:39
0 Replies 
1218 Views
by Admin
23 Mar 2017, 17:00
Pharmacy Practice-Jobs
by Prajith  - 09 Dec 2016, 14:59  - In: Pharm D Jobs
1 Replies 
1291 Views
by Admin
09 Dec 2016, 15:23
2 Replies 
1049 Views
by swathireddy
20 Jul 2018, 12:08

Tags

PharmD Info Online Group Discussion Disc[…]

The Pharmacy Council of India (PCI) has launched a[…]

Indian Association of Colleges of Pharmacy. A/C N[…]

PCI chalks out plans to allay concerns of educatio[…]

WELCOME TO OUR E-LEARN COURSE WORK MODULES